Deltex Medical Group Plc (DEMG.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Income taxes - deferred | N/A | N/A | -57 | -52 | N/A |
| Accounts receivable | 332 | -57 | 148 | 680 | 427 |
| Other Working Capital | -232 | 208 | 434 | 379 | 410 |
| Other Operating Activity | -1,295 | -757 | -816 | -1,075 | -228 |
| Operating Cash Flow | $-1,195 | $-606 | $-291 | $-68 | $609 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9 | -70 | -23 | -6 | -10 |
| Other Investing Activity | -361 | -674 | -621 | -165 | -191 |
| Investing Cash Flow | $-370 | $-744 | $-644 | $-171 | $-201 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -106 | -17 | 43 | -23 | -356 |
| Debt Issued | 250 | 750 | 500 | N/A | N/A |
| Debt Repayment | 0 | -500 | N/A | N/A | N/A |
| Common Stock Issued | 1,887 | 1,340 | 0 | 253 | 322 |
| Other Financing Activity | -245 | -160 | -41 | -40 | -33 |
| Financing Cash Flow | $1,786 | $1,413 | $502 | $190 | $-67 |
| Exchange Rate Effect | 13 | -5 | -7 | -6 | -13 |
| Beginning Cash Position | 471 | 413 | 853 | 908 | 580 |
| End Cash Position | 705 | 471 | 413 | 853 | 908 |
| Net Cash Flow | $221 | $63 | $-433 | $-49 | $341 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,195 | -606 | -291 | -68 | 609 |
| Capital Expenditure | -370 | -744 | -644 | -171 | -260 |
| Free Cash Flow | -1,565 | -1,350 | -935 | -239 | 349 |